<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04373863</url>
  </required_header>
  <id_info>
    <org_study_id>LB1901</org_study_id>
    <nct_id>NCT04373863</nct_id>
  </id_info>
  <brief_title>Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population</brief_title>
  <acronym>LB1901</acronym>
  <official_title>Let's Get to Know Your Health Better? Assessment of Lifestyle, Blood Pressure and Cholesterol in the Population of Employees Libbs Farmacêutica LTDA.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Libbs Farmacêutica LTDA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Libbs Farmacêutica LTDA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project Shall we get to know your health better? Lifestyle assessment, blood pressure and
      cholesterol in the population of Libbs Farmacêutica employeesLTDA.; consists of a study that
      will bring knowledge and enable quantificationof risk factors related to cardiovascular
      diseases in this population above mentioned.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The social relevance of this study is related to the knowledge and quantification of eating
      habits and lifestyles related to cardiovascular diseases in the population of employees, also
      referred to in this document as &quot;employees&quot;, from Libbs Farmacêutica Ltda. Based on an
      observation and statistical analysis of the data obtained in this study, internal policies
      will be promoted that aim to improve eating habits, physical activity and decrease smoking.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 29, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Descriptive questionnaire</measure>
    <time_frame>until December 2020</time_frame>
    <description>Descriptive information about lifestyle and family history and through exams, blood pressure and serum cholesterol values in the population of Libbs Farmacêutica Ltda employees.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of hypercholesterolemia and arterial hypertension</measure>
    <time_frame>until December 2020</time_frame>
    <description>Quantify the prevalence of hypercholesterolemia (serum total cholesterol above 200mg / dL - worst case) and hypertension (systolic blood pressure above 140mmHg or diastolic blood pressure above 90mmHg - worst case)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin (HbA1c) values</measure>
    <time_frame>until December 2020</time_frame>
    <description>Track the glycated hemoglobin (HbA1c) values of the research participants, in order to know the average blood glucose levels in the last 3 months before the day of the exam and quantify the prevalence of participants who have HbA1c above the value considered normal in literature, which is up to 5.6% (best scenario)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Data correlation</measure>
    <time_frame>until December 2020</time_frame>
    <description>Correlate eating habits with socioeconomic characteristics;
Correlate the values of serum cholesterol, blood pressure and glycated hemoglobin with eating habits, level of physical activity practiced and prevalence of smoking</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2815</enrollment>
  <condition>Cholesterol; Lipidosis</condition>
  <condition>Arterial Hypertension</condition>
  <condition>Blood Glucose, High</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This research project will be conducted during various internal and external institutional
        events, and in specific actions carried out at Libbs units located in Barra Funda
        (administrative unit) and in the city of Embu das Artes (production unit).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being an employee Libbs Farmacêutica Ltda;

        Exclusion Criteria:

          -  not applicable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Augusto T Figueiredo</last_name>
    <phone>55 11 3879 2500</phone>
    <phone_ext>1246</phone_ext>
    <email>augusto.figueiredo@libbs.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lara F Yokoya, Dr</last_name>
    <phone>55 11 3879 2500</phone>
    <phone_ext>1987</phone_ext>
    <email>lara.faco@libbs.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Augusto Theodoro de Figueiredo</name>
      <address>
        <city>São Paulo</city>
        <zip>01140050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivienne C Castilho</last_name>
      <phone>55 11 38792500</phone>
      <phone_ext>1568</phone_ext>
      <email>vivienne.castilho@libbs.com.br</email>
    </contact>
    <contact_backup>
      <last_name>Lara F YoKoya</last_name>
      <phone>+55 11 2189-5000</phone>
      <phone_ext>1987</phone_ext>
      <email>lara.faco@libbs.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Manoel P Neto, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glycated hemoglobin</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Arterial Hypertension</keyword>
  <keyword>smoking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Lipidoses</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

